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Abstract: The auxin-inducible degron (AID) system is a powerful tool to induce targeted degradation
of proteins in eukaryotic model organisms. The efficiency of the existing Schizosaccharomyces pombe
AID system is limited due to the fusion of the F-box protein TIR1 protein to the SCF component, Skp1
(Skp1-TIR1). Here, we report an improved AID system for S. pombe that uses the TIR1 from Oryza
sativa (OsTIR1) not fused to Skp1. Furthermore, we demonstrate that degradation efficiency can be
improved by pairing an OsTIR1 auxin-binding site mutant, OsTIR1F74A, with an auxin analogue,
5′adamantyl-IAA (AID2). We provide evidence for the enhanced functionality of the OsTIR1 AID
and AID2 systems by application to the essential DNA replication factor Mcm4 and to a non-essential
recombination protein, Rad52. Unlike AID, no detectable auxin-independent depletion of AID-tagged
proteins was observed using AID2.
Keywords: AID; AID2; degron; auxin; fission yeast; protein degradation
1. Introduction
The auxin-inducible degron (AID) is an effective method for the rapid depletion of
target proteins, allowing control of protein expression and the study of protein function
in vivo [1]. In plants, the physiological role of auxin is to regulate growth and development
by mediating the interaction of the F-box protein transport inhibitor response 1 (TIR1) with
the auxin/indole-3-acetic acid (AUX/IAA) family of transcriptional regulators [2]. TIR1 is
part of the E3 ubiquitin ligase SCF-TIR1 (Skp/Cullin/F-box) complex that recruits an E2
ubiquitin-conjugating enzyme and polyubiquitinates AUX/IAA proteins, targeting them
for degradation by the proteasome.
This degradation pathway can be transferred to non-plant organisms by (1) exoge-
nously expressing the auxin receptor F-box protein, TIR1 and (2) the fusion of an AUX/IAA
auxin-inducible degron (AID) to the protein of interest. As the other components of the SCF
complex are highly conserved, these non-plant cells can be treated with auxin to induce
proteasomal degradation of the AID-tagged protein (Figure 1A). In current AID systems,
Oryza sativa TIR1 (OsTIR1) is the most commonly used auxin receptor F-box protein and
is used in combination with AID tags derived from the Arabidopsis thaliana IAA17 pro-
tein [1,3–9]. However, the fission yeast AID system developed by Kanke et al. [10] uses a
fusion of the A. thaliana TIR1 (AtTIR1) to the F-box-interacting component of the SCF, Skp1
(Skp1-AtTIR1, system termed ‘i-AID’). Overexpression of the Skp1-AtTIR1 fusion using
the constitutive alcohol dehydrogenase adh1 promoter severely inhibited cell growth, so
expression levels were reduced using an attenuated version of the adh1 promoter, Padh15
(Padh15-skp1-AtTIR1) [11]. Despite i-AID causing severe replication defects and cell cycle
arrest in mcm4-AID cells, biologically significant amounts of other target proteins were
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shown to remain after depletion. The system was improved by exogenous expression of
Padh15-skp1-AtTIR1 and Padh15-skp1-OsTIR1 (termed ‘double TIR1′). Double TIR1 combined
with transcription repression of the target protein (termed ‘off -AID’) was used to effectively
deplete Pol1 and Cdc45 [10]. The off -AID system has been used to efficiently regulate
various other proteins including Mcm10 [12], Cdc20 [13], Cnd3 and Smc2 [14] and Bqt1 [15].
A common feature of AID systems is the chronic, auxin-independent proteasome-
mediated degradation of AID-tagged proteins in cells constitutively expressing TIR1. To
circumvent this basal degradation level and its inherent problems, expression of TIR1 is
often transcriptionally regulated. Alternatively, another component of the plants native
auxin signalling machinery, an auxin-response transcription factor (ARF), is co-expressed
as this has been shown to allow near-endogenous expression levels of the target protein in
the absence of auxin [16].
Through a bump-and-hole strategy, a synthetic auxin–receptor pair involving 5-(3-
methoxy-phenyl)-IAA and its complementary auxin-binding pocket mutant AtTIR1F79G was
identified and shown to function orthogonally to endogenous auxin signalling [17]. A screen
of 5-substituted IAA analogues using a yeast two-hybrid system identified 5′adamantyl-
indole-3-acetic acid (5′adamantyl-IAA) which mediates interaction of AtTIR1F79G and IAA3
proteins at a 100-fold lower concentration compared to the natural auxin–TIR1 pair. Fol-
lowing a screen of binding pocket mutants other than glycine, AtTIR1F79A was shown to
interact with IAA3 proteins at picomolar concentrations of 5′adamantyl-IAA, 10,000-fold
lower than for the auxin–TIR1 pair [18]. The corresponding OsTIR1-binding site mu-
tant (OsTIR1F74A) and 5′adamantyl-IAA have recently been shown to function in chicken
DT40 cells at 1,000-fold lower ligand concentration compared to conventional AID/IAA-
OsTIR1WT and shown to function effectively in mammalian cell lines again at significantly
lower ligand concentrations [19]. Using an equivalent bump-and-hole strategy, the syn-
thetic ligand–receptor pair OsTIR1F74G and auxin analogue 5-phenyl-indole-3-acetic acid
(5-Ph-IAA) were shown to interact at nanomolar concentrations and have been used to
rapidly and efficiently deplete mAID-fused proteins in budding yeast, mammalian cells
and mice. This modified system was termed AID version 2 (AID2) [6]. The kinetics of
protein depletion were quicker when compared to the original AID system and depletion
could be induced with several hundred-fold lower ligand concentration. Moreover, no
detectable basal degradation was observed using AID2.
In fission yeast, a mechanism for the selective removal of meiosis-specific mRNAs in
mitotic cells has been characterised. The removal involves the YTH domain-containing
protein Mmi1 [20], which binds meiosis-specific mRNAs containing Determinant of Se-
lective Removal (DSR) sequences, usually located at the 3′ end of the transcript. Mmi1 is
only functional in mitotic, but not meiotic, cells and greatly increases transcript turnover
by directing DSR-containing transcripts to the nuclear exosomes for degradation [20,21].
By deletion analysis, the DSR elements of ssm4, rec8 and spo5 mRNAs were identified [20].
Further studies have identified a hexanucleotide motif, U(U/C)AAAC, that is highly en-
riched in the DSR elements and have shown that tandem repeats of this motif can function
as an artificial DSR in heterologous gene systems [22,23].
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Figure 1. AID/OsTIR1WT and AID2/OsTIR1F74A systems in S. pombe. (A) Schematic illustration showing AID/OsTIR1WT
and AID2/OsTIR1F74A systems. AID: As the Skp1, Cullin and F-box protein complex (SCF) is highly conserved among
eukaryotes, exogenously expressed plant F-box protein OsTIR1 can form a functional SCF complex in S. pombe. The protein
of interest (POI) is fused to the AID degron (AID). The synthetic auxin 1-naphthaleneacetic acid (NAA) binds OsTIR1 and
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promotes interaction between OsTIR1 and the AID degron. SCF-OsTIR1 acts as an E3 ubiquitin ligase to recruit an E2
ubiquitin-conjugating enzyme, resulting in the poly-ubiquitination of the AID tag. Finally, the POI is degraded by the
proteasome. AID2: The process is analogous to AID, but pairs the OsTIR1 auxin-binding site mutant F74A and the
5’-substituted auxin analogue 5′adamantyl-indole-3-acetic acid (5′a-IAA). (B) Schematic illustration showing the arg3-D4
loci engineered to constitutively express OsTIR1WT or OsTIR1F74A (NLS: nuclear localisation signal). (C) Representative
immunoblot on total protein extract from wild-typeWT (AW279), OsTIR1WT (AW1762) and OsTIR1F74A (AW1703) cells
detected using anti-OsTIR1 antibody. Anti-tubulin was used as a loading control. (D) Representative growth curves of
isogenic wild-type (WT—(AW279)), OsTIR1WT (AW1762) and OsTIR1F74A (AW1703) cells. Cells were grown in YE media at
30 ◦C with constant shaking (180 rpm). Optical density (OD) was measured at 1h intervals for total 10 h. Timeseries of
log 2-transformed OD600 measurements are presented. Black lines represent linear regression models and are the mean of
two technical repeats. Slopes of linear regression models (k) and calculated doubling times are indicated. (E) Plasmids to
C-terminally AID-tag a protein of interest (linker: flexible 10 amino acid linker (Gly-Gly-Ser-Gly-Gly-Ser-Gly-Ser-Gly-Ala),
spo5DSR: spo5 Determinant of Selective Removal element, eDSR: enhanced spo5DSR element, TAG: epitope tag, number in
parenthesis after plasmid name: Addgene ID). (F) Primer sequences to amplify aid-(TAG)-(DSR)-Turg1-kanMX6 construct.
* Reading frame for tag is indicated. (G) Isogenic strains with the indicated genotypes (mcm4+ (AW279), mcm4-AID (AW1893),
Skp1-AtTIR1 (AW1942), mcm4-AID Skp1-AtTIR1 (AW1949), OsTIR1WT (AW1762), mcm4-AID, OsTIR1WT (AW1923)) were
spotted onto YEA plates and plates containing 500 µM NAA. Plates were grown at the indicated temperatures for 3 days.
The experiment was repeated and similar results were obtained.
Here, we describe an improved AID system for fission yeast that overcomes the
drawbacks of the original Kanke et al. [10] approach. We constructed two sets of plasmid
vector for this study. One set was designed to stably integrate expression constructs at the
arg3-D4 locus [24]. These plasmids were used to insert and constitutively express a genomic
copy of the OsTIR1 receptor, OsTIR1WT, or the AID2 variant, OsTIR1F74A, using the full-
strength S. pombe alcohol dehydrogenase (adh1) promoter. The second set of plasmids
was designed to allow AID tagging of the protein of interest at the C-terminus. These
plasmids include a series of epitope tag sequences for detection of AID-tagged proteins
by commercially available antibodies including HA, Myc and V5. The spo5DSR element
and an improved engineered version of the spo5DSR element, termed ‘eDSR’, are also
included as an option that will act to constitutively reduce AID-tagged protein levels. The
addition of either the synthetic auxin 1-naphthaleneacetic acid (NAA) (OsTIR1WT/AID)
or the 5-substituted auxin 5′adamantyl-IAA (OsTIR1F74A/AID2), allowed the creation of
conditional loss of function mutants of the MCM complex component Mcm4 to be created
in cells grown at 30 ◦C without fusing to Skp1. For AID2, we observed faster depletion
kinetics at lower ligand concentrations as compared to AID and no basal degradation
of AID-tagged Mcm4. However, for the non-essential recombination protein Rad52, a
complete conditional null phenotype was not obtained, despite the presence of DSR
sequences: we observed that very low levels of Rad52 activity remained.
2. Materials and Methods
2.1. Strains and Growth Conditions
Strains used in this work are listed in Table 1. All strains were grown at 30 ◦C unless
stated otherwise. The media composition was as described by Moreno et al. [25]. For
selection of G418 and phleomycin-resistant cells, G418 disulphate (Formedium, Hunstan-
ton, UK) or phleomycin (Fisher BioReagents, Waltham, MA, USA) was added to YEA
plates at a final concentration of 200 and 30 µg/mL, respectively. Synthetic plant auxin
1-naphthaleneacetic acid (NAA) (Sigma, St. Louis, MO, USA) powder was dissolved in
80% ethanol to the required concentration (0.5 M). The final NAA concentration used
was 500 µM. NAA stock was prepared fresh prior to use and unused stock discarded.
5’adamantyl-IAA was dissolved in DMSO to the required concentration (1 mM) and
aliquots stored at −20 ◦C. Growth curve doubling times were calculated using the formula
DT = 1/k, where DT stands for doubling time and k represents the slope of linear regression
computed from a timeseries of log 2-transformed OD measurements [26].
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Table 1. Strains used in this study.







AW1680 rad52-HA-AID-Turg1:kanMX6, arg3::bleMX6-arg3+-Padh1-OsTIR1F74A-TADH1 h-
AW1681 rad52-HA-AID-Turg1:kanMX6, arg3::bleMX6-arg3+-Padh1-OsTIR1F74A-TADH1, h+
AW1682 rad52-HA-AID-spo5DSR-Turg1:kanMX6, arg3::bleMX6-arg3+-Padh1-OsTIR1F74A-TADH1, h+









AW1923 mcm4-AID-Turg1:kanMX6, arg3::bleMX6-arg3+-Padh1-OsTIR1WT-TADH1 h+
AW1925 mcm4-Turg1:kanMX6, arg3::bleMX6-arg3+-Padh1-OsTIR1F74A-TADH1 h+
AW1935 mcm4-AID-V5-Turg1:kanMX6, arg3::bleMX6-arg3+-Padh1-OsTIR1WT-TADH1 h+
AW1937 mcm4-AID-V5-Turg1:kanMX6, arg3::bleMX6-arg3+-Padh1-OsTIR1F74A-TADH1 h+
AW1942 ade6::ade6+-Padh15-skp1-AtTIR1-2NLS-9myc h+
AW1949 mcm4-AID-Turg1:kanMX6, ade6::ade6+-Padh15-skp1-AtTIR1-2NLS-9myc h+
AW1962 rad52-AID-Turg1:kanMX6, arg3::bleMX6-arg3+-Padh1-OsTIR1F74A-TADH1 h+
AW1968 rad52-AID-V5-Turg1:kanMX6, arg3::bleMX6-arg3+-Padh1-OsTIR1F74A-TADH1 h+
AW1970 rad52-AID-spo5DSR-Turg1:kanMX6, arg3::bleMX6-arg3+-Padh1-OsTIR1F74A-TADH1 h+
AW1976 rad52-AID-V5-spo5DSR-Turg1:kanMX6, arg3::bleMX6-arg3+-Padh1-OsTIR1F74A-TADH1 h+
AW1990 rad52-AID-Turg1:kanMX6, arg3::bleMX6-arg3+-Padh1-OsTIR1WT-TADH1 h+
AW1996 rad52-AID-V5-Turg1:kanMX6, arg3::bleMX6-arg3+-Padh1-OsTIR1WT-TADH1 h+
AW2011 rad52-AID-eDSR-Turg1:kanMX6 h+
AW2017 rad52-AID-V5-eDSR-Turg1:kanMX6 h+
AW2024 rad52-AID-eDSR-Turg1:kanMX6, arg3::bleMX6-arg3+-Padh1-OsTIR1F74A-TADH1 h+
AW2026 rad52-AID-V5-eDSR-Turg1:kanMX6, arg3::bleMX6-arg3+-Padh1-OsTIR1F74A-TADH1 h+
2.2. Cloning and Plasmid Construction
Q5 High-Fidelity 2X Master Mix was used for all PCR reactions in accordance to the
manufacturer’s instructions. For all cloning procedures, NEBuilder HiFi DNA Assembly
Master Mix was used in accordance to the manufacturer’s instructions. Escherichia coli strain
DH5α was used for transformations and plasmid isolation. Synthesised gene fragments and
custom oligonucleotide primers (Table 2) were ordered from Integrated DNA Technologies.
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Table 2. Sequences of oligonucleotide primers used in this study.

























2.3. S. pombe arg3-D4 Integration Expression Vectors
An NdeI site contained within the pUC19 backbone was removed by restriction with
NdeI, blunting the overhangs using Mung Bean Nuclease (New England Biolabs, Ipswich,
MA, USA) and religation using T4 DNA ligase (New England Biolabs). The resulting plas-
mid was termed pUC19*, where * denotes removal of the NdeI recognition site from plasmid
backbone (CATATG converted to CATG). The S. pombe arg3-D4 locus was sequenced and
the deleted genomic fragment identified. The deleted fragment and approximately 500 bp
each side of the deletion site were gene synthesised. Gene synthesis allowed for the re-
moval of unwanted restriction enzymes sites, insertion of a multiple clone site (MCS -
NheI-NdeI-SphI-XmaI-SacI-PstI-SalI-SpeI) and insertion NotI restriction enzyme sites for the
removal of the linear arg3 construct. The gene fragment was cloned into EcoRI/HindIII
restricted pUC19* to create MCS- Sp.arg3+/pUC19*. The 820 bp of the S. pombe adh1
promoter sequence (TATA box = TATAAATA) was amplified from total genomic DNA
using primers P1 and P2 and the resulting fragment cloned into NheI/NdeI restricted
Genes 2021, 12, 882 7 of 23
MCS-Sp.arg3+/pUC19* to create Padh1-MCS-Sp.arg3+/pUC19*. Approximately 820 bp
of the S. pombe adh15 (TATA box = TAAATATA) and adh81 (TATA box = AT) promoter
sequences were amplified from pKM104 and pKM105 [10] using primers P3 and P4 and
the resulting fragment cloned into NheI/NdeI restricted MCS-Sp.arg3+/pUC19* to cre-
ate Padh15-MCS-Sp.arg3+/pUC19* and Padh81-MCS-Sp.arg3+/pUC19*, respectively. Then,
159 bp of the Saccharomyces cerevisiae ADH1 terminator was amplified from pAW8_TAP [27]
using primers P5 and P6 and the fragment cloned into SalI/SpeI restricted Padh1-MCS-
Sp.arg3+/pUC19*, Padh15-MCS-Sp.arg3+/pUC19* and Padh81-MCS-Sp.arg3+/pUC19* to cre-
ate Padh1-MCS-TADH1-Sp.arg3+/pUC19*, Padh15-MCS-TADH1-Sp.arg3+/pUC19* and Padh81-
MCS-TADH1-Sp.arg3+/pUC19*, respectively (MCS = NdeI-XmaI-SacI-PstI-SalI) (Figure S1).
2.4. AID-Tagging Constructs
The IAA17 degron tag sequence was amplified from the plasmid template pMK43 [1]
using primers P7 and P8 and the fragment cloned into SphI/AscI restricted pAW8_TAP [27],
replacing the TAP tag sequence, to create pAW8-aid. Primer P7 encodes a ten amino acid
flexible linker sequence (Gly-Gly-Ser-Gly-Gly-Ser-Gly-Ser-Gly-Ala). Primer P8 replaces re-
striction enzyme site AscI with NheI. To help identify the presence of the kanMX6 antibiotic
selection marker, the plasmid was renamed pAW8-aid:kanMX6. 533 bp of the S. pombe urg1
terminator sequence was amplified from total S. pombe genomic DNA using primers P9
and P10 and the product cloned into the NheI/BglII restricted pAW8-aid:kanMX6, replacing
the S. cerevisiae ADH1 terminator sequence, to create pAW8-aid-Turg1:kanMX6. Primer P10
inserted the restriction enzyme recognition site XmaI adjacent to the NheI site. The 157 bp
DSR element of the S. pombe spo5 gene as identified by Harigaya et al. [20] was ampli-
fied from pAW8ENdeI-spo5DSR [23] using primers P11 and P12 the product cloned into
NheI/XmaI restricted pAW8-aid-Turg1:kanMX6 to create pAW8-aid-spo5DSR-Turg1:kanMX6.
Three copies of the human influenza hemagglutinin (HA) protein tag sequence were ampli-
fied from plasmid pAW8_3HA [28] using primers P13 and P14 or P13 and P15 the products
cloned into NheI-restricted pAW8-aid-Turg1:kanMX6 and NheI-restricted pAW8-aid-spo5DSR-
Turg1:kanMX6, respectively, to create pAW8-aid-3HA-Turg1:kanMX6 and pAW8-aid-3HA-
spo5DSR-Turg1:kanMX6. The forward primer P13 removed the AID-tag stop codon and
inserted a small flexible six amino acid linker (Gly-Ala-Gly-Ala-Gly-Ala) between the AID
and 3HA tags. Five copies of the human c-myc (Myc) epitope were amplified from plasmid
pAW8_13Myc [27] using primers P16 and P17 or P16 and P18 and the resulting fragments
cloned into NheI-restricted pAW8-aid-Turg1:kanMX6 and NheI-restricted pAW8-aid-spo5DSR-
Turg1:kanMX6, respectively, to create pAW8-aid-5Myc-Turg1:kanMX6 and pAW8-aid-5Myc-
spo5DSR-Turg1:kanMX6. The forward primer P16 removed the AID-tag stop codon and
inserted a small flexible six amino acid linker (Gly-Ala-Gly-Ala-Gly-Ala) between the
AID and 5Myc tags. A sequence encoding a single copy of the simian virus 5-derived V5
tag was human codon optimised and gene synthesised and cloned into NheI-restricted
pAW8-aid-Turg1:kanMX6 to create pAW8-aid-V5-Turg1:kanMX6. A second sequence was
synthesised allowing cloning into NheI-restricted pAW8-aid-spo5DSR-Turg1:kanMX6 to cre-
ate pAW8-aid-V5-spo5DSR-Turg1:kanMX6. The synthesised sequences removed the AID-tag
stop codon and inserted a small flexible six amino acid linker (Gly-Ala-Gly-Ala-Gly-Ala)
between the AID and V5 tags.
A mutated version of spo5DSR element was designed to contain two additional DSR
core motifs and was termed ‘eDSR’ (Figure S2). A series of eDSR fragments compatible
for cloning into plasmids pAW8-aid-Turg1:kanMX6, pAW8-aid-3HA-Turg1:kanMX6, pAW8-
aid-5Myc-Turg1:kanMX6 and pAW8-aid-V5-Turg1:kanMX6 were synthesised and cloned
into their respective NheI-restricted plasmids to create pAW8-aid-eDSR-Turg1:kanMX6,
pAW8-aid-3HA-eDSR-Turg1:kanMX6, pAW8-aid-5Myc-eDSR-Turg1:kanMX6 and pAW8-aid-
V5-eDSR-Turg1:kanMX6.
All plasmid constructs were confirmed by sequencing. All plasmid constructs and
sequences are available from Addgene (see Figure 1E for Addgene ID numbers).
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2.5. Yeast Transformations
All yeast transformations were performed using a lithium acetate method [28]. For
insertion of the phleomycin/bleomycin resistance cassette adjacent to the arg3-D4 locus,
a linear PCR fragment generated using primers P19 and P20 and the plasmid template
pFA6a-bleMX6 [29] was used to transform strain arg3-D4 (AW1502). After selection on
YEA plates supplemented with 30 mg/mL phleomycin, transformants were confirmed by
genomic PCR and sequencing. This created strain AW1655 (bleMX6-arg3-D4) (Figure S1).
To fuse the AID-tag at the C-terminus of Mcm4 and Rad52, primers P21 and P22 (Mcm4) or
primers P23 and P24 (Rad52) were used to generate linear PCR fragments from the relevant
pAW8-aid-Turg1:kanMX6 plasmid described above and used to transform strain AW279
(WT h+). Transformants were selected on YEA plates supplemented with 200 mg/mL G418
and confirmed using genomic PCR and sequencing.
2.6. Spot Tests
Cell cultures grown in YE media 30 ◦C in YE medium were adjusted to a density of
1 × 107 cells/mL. A series of 10-fold dilutions in sterile water was performed for each
strain and 7 µL drops were spotted onto YEA medium plates with or without supplements.
2.7. Preparation of Total Cell Extract and Western Blot Analysis
Preparation of cell extracts for SDS-PAGE and Western blotting was performed as
previously described [30] except NaN3 was added to the cell culture sample to a final
concentration of 0.1% prior to centrifugation. For protein detection, the following commer-
cially available antibodies were used. Primary antibodies: anti-V5 (Bio-Rad, # MCA1360)
(diluted 1:5,000), anti-OsTIR1 (MBL, #PD048) (diluted 1:1,000) and anti-α tubulin (Sigma,
#T5168) (diluted 1:10,000). Secondary antibodies: anti-mouse IgG HRP (Dako, #P0260) and
anti-rabbit IgG HRP (Dako, #P0217), both diluted 1:5,000. All antibodies were incubated in
phosphate-buffered saline, 0.1% v/v Tween 20 detergent (PBST) containing 3% skimmed
milk powder except anti-OsTIR1, which was incubated in PBST containing 5% skimmed
milk powder. For quantification of protein levels, Amersham ImageQuant LAS4000 West-
ern blot imaging system was used and resulting images analysed using ImageQuant TL
software (version 1.2) ( GE Healthcare, Chicago, IL, USA).
2.8. Synthesis of 2-[5-(adamantan-1-yl)-1H-indol-3-yl]Acetic Acid (5′-adamantyl-IAA)
5′Adamantyl-IAA was synthesised essentially as described previously [18]. Solvents
were used as received, including deuterated solvents for NMR spectroscopy. NMR spec-
tra were recorded on a Varian NMR 400 (1H 399.5 MHz; 13C{1H} 100.5 MHz or 500 (1H
499.9 MHz; 13C{1H} 125.7 MHz). Chemical shifts are reported in ppm. Spectra are refer-
enced to the corresponding protic solvent (1H) or signals of the solvent (13C). Reactions
were monitored by TLC on commercially available glass silica gel plates (60 Å, F254). The
mobile phase was usually a solvent mixture and the visualisation was undertaken using
UV light. Chromatographic purifications were carried out on an ISCO Combi Flash RF 75
or a 150 PSI purification unit. Gel columns. LC–MS purity analyses were undertaken using
a 5 µm C18 110 Å column. Percentage purities were performed using a 30 min method
in water/acetonitrile with 0.1% formic acid (5 min at 5%, 5−95% over 20 min, 5 min at
95%) with the UV set to 254 nm. High-resolution mass spectrometry was carried out at the
University of Sussex.
2.8.1. N-(4-(adamantan-1-yl)phenyl)acetamide
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pFA6a-bl MX6 [29] was use  to transform strain arg3-D4 (AW1502). After selection on 
YEA plates supplemented with 30 mg/mL phleomycin, transformants were confirmed by 
genomic PCR and sequencing. This created strain AW1655 (bleMX6-arg3-D4) (Figure S1). 
To fuse the AID-tag at the C-ter inus of Mcm4 and Rad52, primers P21 and P22 (Mcm4) 
or primers P23 and P24 (Rad52) were used to generate linear PCR fragments from the 
relevant pAW8-aid-Turg1:kanMX6 plasmid described above and used to transform strain 
AW279 (WT h+). Transformants were selected on YEA plates supplemented with 200 
mg/mL G418 and confirmed using genomic PCR and sequencing. 
2.6. Spot Tests 
Cell cultures grown in YE media 30 °C in YE medium were adjusted to a density of 1 
× 107 cells/mL. A series of 10-fold dilutions in sterile water was performed for each strain 
and 7 L drops were spotted onto YEA medium plates with or without supplements. 
2.7. Preparation of Total Cell Extract and Western Blot Analysis 
Preparation of cell extracts for SDS-PAGE and Western blotting was performed as 
previously described [30] except NaN3 was added to the cell culture sample to a final con-
centration of 0.1% prior to centrifugation. For protein detection, the following commer-
cially available antibodies were used. Primary antibodies: anti-V5 (Bio-Rad, # MCA1360) 
(diluted 1:5,000), anti-OsTIR1 (MBL, #PD048) (diluted 1:1,000) and anti-α tubulin (Sigma, 
#T5168) (dilute  1:10,000). Secondary antibodies: anti- ouse IgG HRP (Dako, #P0260) and 
anti-r bbit IgG HRP (Dako, #P0217), both diluted 1:5,000. All antibodies were incubated 
in phosphate-buffered saline, 0.1% v/v Tween 20 detergent (PBST) containing 3% 
skimmed milk powd r except anti-OsTIR1, which was incubated in PBST containing 5% 
skimmed milk powder. For quantification of protein levels, Amersham ImageQuant 
LAS4000 W stern blot im ging system was used and r ulting images analysed using Im-
ageQuant TL software (version 1.2) ( GE He lthcare, Chicago, IL, US). 
2.8. Synthesis of 2-[5-(adamantan-1-yl)-1H-indol-3-yl]Acetic Acid (5′-adamantyl-IAA) 
5′Adamantyl-IAA was synthesised essentially as described previously [18]. Solvents 
w re used as received, in luding deuterated solvents for NMR spectroscopy. NMR spec-
tra were r corded on a Varian NMR 400 (1H 399.5 MHz; 13C{1H} 100.5 MHz or 500 (1H 
499.9 MHz; 13C{1H} 125.7 MHz). Chemical shifts are reported in ppm. Spectra are refer-
enced to the corresponding protic solvent (1H) or signals of the solvent (13C). Reactions 
were monitored by TLC on commercially available glass silica gel plates (60 Å , F254). The 
obile phase was usually a solvent mixture and the visualisation was undertaken using 
UV light. Chromatographic purifications were carried out on an ISCO Combi Flash RF 75 
or a 150 PSI purification unit. Gel columns. LC–MS purity analyses were undertaken using 
a 5 μm C18 110 Å column. Percentage purities were performed using a 30 min method in 
water/acetonitrile with 0.1% formic acid (5 min at 5%, 5−95% over 20 min, 5 min at 95%) 
with the UV set to 254 nm. High-resolution mass spectrometry was carried out at the Uni-
versity of Sussex. 
2.8.1. N-(4-(adamantan-1-yl)phenyl)acetamide 
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To a mixture of acetanilide (5.07 g, 37.50 mmol), 1-bromoadamantane (8.87 g, 41.25 mmol)
and 1,1,2,2-tetrachloroethane (50 mL) was added zinc chloride (10.22 g, 75.00 mmol) and
the resulting mixture heated to 80 ◦C and stirred for 72 h under an argon atmosphere. The
reaction was cooled to ambient temperature and to the mixture was added 1 M aqueous
HCl (150 mL) and dichloromethane (DCM) (100 mL). The resulting biphasic mixture was
separated, and the aqueous phase extracted with DCM (2× 100 mL). The combined organic
extracts were dried over anhydrous MgSO4, filtered, and concentrated under reduced
pressure. The resulting residue was purified by automated column chromatography (n-
hexane/EtOAc, 100:0–30:70, 100 g SiO2). The appropriate fractions were combined and
concentrated under reduced pressure to give N-(4-(adamantan-1-yl)phenyl)acetamide as
a white solid (5.14 g, 51%). LCMS (UV, ESI) Rt = 23.52 min, [M-H]+ m/z = 270.1, 88%
purity. 1H NMR (600 MHz, d6-DMSO): δ = 9.82 (1H, s), 7.50–7.46 (2H, m), 7.27–7.23 (2H,
m), 2.06–2.02 (3H, m), 2.01 (3H, s), 1.84–1.80 (6H, m), 1.76–1.68 (6H, m).
2.8.2. N-(4-(adamantan-1-yl)-2-iodophenyl)acetamide
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mmol) and the resulting mixture heated to 80 °C and stirred for 72 h under an argon at-
mosphere. The reaction was cooled to ambient temperature and to the mixture was added 
1 M aqueous HCl (150 mL) and dichloromethane (DCM) (100 mL). The resulting biphasic 
mixture was separated, and the aqueous phase extracted with DCM (2 × 100 mL). The 
combined organic extracts were dried over anhydrous MgSO4, filtered, and concentrated 
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270.1, 88% purity. 1H NMR (600 MHz, d6-DMSO): δ = 9.82 (1H, s), 7.50–7.46 (2H, m), 7.27–
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2.8.2. N-(4-(adamantan-1-yl)-2-iodophenyl)acetamide 
 
To a mixture of N-(4-(adamantan-1-yl)phenyl)acetamide (1.82 g, 6.76 mmol), 
TsOH.H2O (128 mg, 0.66 mmol), and MeCN (100 mL) was added NIS (1.67 g, 7.43 mmol) 
and the resulting mixture was stirred under an argon atmosphere for 24 h at ambient tem-
perature. The mixture was concentrated under reduced pressure and to the residue EtOAc 
(50 mL) was added and saturated aqueous NaHCO3 (50 mL). The resulting biphasic mix-
ture was separated, and the aqueous phase extracted with EtOAc (3 × 50 mL). The com-
bined organic extracts were washed with brine, dried over anhydrous MgSO4, filtered, 
and concentrated under reduced pressure to give a brown solid (2.7 g). The solid was 
purified by automated flash column chromatography (n-hexane/EtOAc, 100:0–50:50, 30 g 
SiO2). The appropriate fractions were combined and concentrated under reduced pressure 
to give N-(4-(adamantan-1-yl)-2-iodophenyl)acetamide as a light orange solid (2.62 g, 
98%). LCMS (UV, ESI) Rt = 25.59 min, [M-H]+ m/z = 396.0, 93% purity. 1H NMR (600 MHz, 
d6-DMSO): δ = 9.36 (1H, s), 7.75 (1H, d, J = 2.2 Hz), 7.36 (1H, dd, J = 8.4, 2.2 Hz), 7.30 (1H, 
d, J = 8.4 Hz), 2.07–2.02 (3H, m), 2.03 (3H, s), 1.85–1.82 (6H, m), 1.76–1.69 (6H, m). 
2.8.3. N-(4-(adamantan-1-yl)-2-((trimethylsilyl)ethynyl)phenyl)acetamide 
 
To N-(4-(adamantan-1-yl)-2-iodophenyl)acetamide (1.00 g, 2.53 mmol), Pd(PPh3)2Cl2 
(44 mg, 0.063 mmol), and CuI (24 mg, 0.127 mmol) was added THF:NEt3 (1:1) (25 mL) 
followed by trimethylsilyacetylene (456 µL, 3.29 mmol). The resulting mixture was stirred 
under argon for 16 h at ambient temperature. The reaction was concentrated under re-
duced pressure and purified by automated flash column chromatography (n-hex-
ane/EtOAc, 100:0–60:40, 40 g SiO2). The appropriate fractions were combined and concen-
trated under reduced pressure to give N-(4-(adamantan-1-yl)-2-((trimethylsi-
lyl)ethynyl)phenyl)acetamide as a brown solid (740 mg, 80%). LCMS (UV, ESI) Rt = 29.64 
min, [M-H]+ m/z = did not ionise, 94% purity. 1H NMR (600 MHz, d6-DMSO): δ = 9.13 (1H, 
s), 7.60 (1H, d, J = 8.8 Hz), 7.39–7.34 (2H, m), 2.08–2.03 (6H, m), 1.85–1.81 (6H, m), 1.74–
1.70 (6H, m), 0.25 (9H, s). 
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resulting mixture was stirred under an argon atmosphere for 24 h at ambient temperature.
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separated, and the aqueous phase extracted with EtOAc (3 × 50 mL). The combined
organic extracts were washed with brine, dried over anhydrous MgSO4, filtered, and
concentrated under reduced pressure to give a brown solid (2.7 g). The solid was purified
by automated flash column chromatography (n-hexane/EtOAc, 100:0–50:50, 30 g SiO2).
The appropriate fractions were combined and concentrated under reduced pressure to give
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To N-(4-(adamantan-1-yl)-2-iodophenyl)acet ide (1.00 g, 2.53 mmol), Pd(PPh3)2Cl2
(44 mg, 0.063 mmol), and CuI (2 mg, 0.127 mmol) w s added THF:NEt3 (1:1) (25 mL)
followed by trimethylsilyacetylene (456 µL, 3.29 mmol). The resulting mixture was stirred
under argon for 16 h at ambient temp ature. The reaction was co centrat d under reduced
pressure and purified by automated flash column chromatography (n-hexane/EtOAc, 100:0–
60:40, 40 g SiO2). The appropriate fractions were combined and concentrated under reduced
pressure to give N-(4-(adamantan-1-yl)-2-((trimethylsilyl)ethynyl)phenyl)acetamide as a
brown solid (740 mg, 80%). LCMS (UV, ESI) Rt = 29.64 min, [M-H]+ m/z = did not ionise,
94% purity. 1H NMR (600 MHz, d6-DMSO): δ 9.13 (1H, s), 7.60 (1H, d, J = 8.8 Hz),
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2.8.4. 5-(Adamantan-1-yl)-1H-indole





To a mixture of N-(4-(adamantan-1-yl)-2-((trimethylsilyl)ethynyl)phenyl)acetamide 
(630 mg, 1.72 mmol) and anhydrous THF (16 mL) was added tetrabutylammonium fluo-
ride (TBAF) (1 M in THF) (2.50 mL). The resulting mixture was heated to 80 °C and stirred 
for 16 h under an argon atmosphere. The reaction was cooled to ambient temperature and 
to the mixture was added EtOAc (15 mL) and water (15 mL). The resulting biphasic mix-
ture was separated, and the aqueous phase extracted with EtOAc (3 × 15 mL). The com-
bined organic extracts were washed with brine (25 mL), dried over anhydrous MgSO4, 
filtered, and concentrated under reduced pressure to give a brown oil (500 mg). The re-
sulting residue was purified by automated flash column chromatography (n-hex-
ane/EtOAc, 100:0–70:30, 24 g SiO2). The appropriate fractions were combined and concen-
trated under reduced pressure to give 5-(adamantan-1-yl)-1H-indole as a pale yellow solid 
(330 mg, 76%). LCMS (UV, ESI) Rt = 27.19 min, [M-H]+ m/z = 252.1, 91% purity. 1H NMR 
(600 MHz, d6-DMSO): δ = 10.88 (1H, s), 7.44 (1H, s), 7.30 (1H, d, J = 8.8 Hz), 7.26 (1H, m), 
7.14 (1H, dd, J = 8.8, 1.8 Hz), 6.35 (1H, m), 2.09–2.05 (3H, m), 1.92–1.89 (6H, m), 1.78–1.72 
(6H, m). 
2.8.5. Methyl 2-(5-(adamantan-1-yl)-1H-indol-3-yl)-2-oxoacetate 
 
To a mixture of 5-(adamantan-1-yl)-1H-indole (294 mg, 1.17 mmol) and anhydrous 
Et2O (10 mL) was added oxalyl chloride (148 µL, 1.75 mmol) and the resulting mixture 
stirred for 16 h at ambient temperature under argon. To the mixture was added MeOH 
(10 mL) and the resulting mixture stirred for 15 min. The resulting mixture was concen-
trated under reduced pressure to give a yellow solid of sufficient purity to be utilised in 
the subsequent reaction without further manipulation. 
2.8.6. 2-[5-(Adamantan-1-yl)-1H-indol-3-yl]Acetic Acid 
 
To a mixture of crude methyl 2-(5-(adamantan-1-yl)-1H-indol-3-yl)-2-oxoacetate (395 
mg, 1.17 mmol), NaH2PO2.H2O (1.24 g, 11.70 mmol), and H2O/1,4-dioxane (1:5) (10 mL) 
was added Pd/C (10%) (128 mg, 0.12 mmol). The resulting mixture was heated to 100 °C 
and stirred for 72 h under an argon atmosphere. The reaction was cooled to ambient tem-
perature and filtered through Celite® , washing with EtOAc (25 mL). To the mixture was 
added 2M aqueous HCl (25 mL) and the resulting biphasic mixture separated. The organic 
phase was washed with brine (25 mL), dried over anhydrous MgSO4, filtered, and con-
centrated under reduced pressure to give a light red gum (550 mg). The resulting residue 
was purified by automated flash column chromatography (n-hexane/EtOAc, 100:0–70:30, 
24 g SiO2). The appropriate fractions were combined and concentrated under reduced 
pressure to give 2-(5-(adamantan-1-yl)-1H-indol-3-yl)acetic acid as a white solid (129 mg, 
To a mixture of N-(4-(adamantan-1-yl)-2-((trimethylsilyl)ethynyl)phenyl)acetamide
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was separated, and the aqueous phase extracted with EtOAc (3 × 15 mL). The combined
organic extracts were washed with brine (25 mL), dried over anhydrous MgSO4, filtered,
and concentrated under reduced pressure to give a brown oil (500 mg). The resulting
residue was purified by automated flash column chromatography (n-hexane/EtOAc, 100:0–
70:30, 24 g SiO2). The appropriate fractions were combined and concentrated under reduced
pressure to give 5-(adamantan-1-yl)-1H-indole as a pale yellow solid (330 mg, 76%). LCMS
(UV, ESI) Rt = 27.19 min, [M-H]+ m/z = 252.1, 91% purity. 1H NMR (600 MHz, d6-D SO):
δ = 10.88 (1H, s), 7.44 (1H, s), 7.30 (1H, d, J = 8.8 Hz), 7.26 (1H, m), 7.14 (1H, dd, J = 8.8,
1.8 Hz), 6.35 (1H, m), 2.09–2.05 (3H, m), 1.92–1.89 (6H, m), 1.78–1.72 (6 , ).
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stirred for 16 h at ambient temperature under argon. To the mixture was added MeOH 
(10 mL) and the resulting mixture stirred for 15 min. The resulting mixture was concen-
trated under reduced pressure to give a yellow solid of sufficient purity to be utilised in 
the subsequent reaction without further manipulation. 
2.8.6. 2-[5-(Adamantan-1-yl)-1H-indol-3-yl]Acetic Acid 
 
To a mixture of crude methyl 2-(5-(adamantan-1-yl)-1H-indol-3-yl)-2-oxoacetate (395 
mg, 1.17 mmol), NaH2PO2.H2O (1.24 g, 11.70 mmol), and H2O/1,4-dioxane (1:5) (10 mL) 
was added Pd/C (10%) (128 mg, 0.12 mmol). The resulting mixture was heated to 100 °C 
and stirred for 72 h under an argon atmosphere. The reaction was cooled to ambient tem-
perature and filtered through Celite® , washing with EtOAc (25 mL). To the mixture was 
added 2M aqueous HCl (25 mL) and the resulting biphasic mixture separated. The organic 
phase was washed with brine (25 mL), dried over anhydrous MgSO4, filtered, and con-
centrated under reduced pressure to give a light red gum (550 mg). The resulting residue 
was purified by automated flash column chromatography (n-hexane/EtOAc, 100:0–70:30, 
24 g SiO2). The appropriate fractions were combined and concentrated under reduced 
pressure to give 2-(5-(adamantan-1-yl)-1H-indol-3-yl)acetic acid as a white solid (129 mg, 
To a mixture of crude methyl 2-(5-(adamantan-1-yl)-1H-indol-3-yl)-2-oxoacetate
(395 mg, 1.17 mmol), NaH2PO2.H2O (1.24 g, 11.70 mmol), and H2O/1,4-dioxane (1:5)
(10 mL) was added Pd/C (10%) (128 mg, 0.12 mmol). The resulting mixture was heated
to 100 ◦C and stirred for 72 h under an argon atmosphere. The reaction was cooled to
ambient temperature and filtered through Celite®, washing with EtOAc (25 mL). To the
mixture was added 2M aqueous HCl ( 5 mL) and the resulting biphasic mixture separ ted.
The organic phase was washed with brine (25 mL), dried over anhydrous MgSO4, filtere ,
and concentrated under reduced pressure to give a light red gum (550 mg). The result-
ing residue was purified by automated flash col mn chrom tography (n-hexane/EtOAc,
100:0–70:30, 24 g SiO2). The appropriate fractions were combined a d concentrated under
reduced pressure to give 2-(5-(adamantan-1-yl)-1H in ol-3-yl)acetic acid as a white solid
(129 mg, 36% over 2 steps). LCMS (UV, ESI) Rt = 22.49 min, [M-H]+ m/z = 310.0, 96% purity.
1H NMR (600 MHz, d6-DMSO): δ = 12.11 (1H, s), 10.73 (1H, s), 7.42 (1H, m), 7.27 (1H, d,
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J = 8.8 Hz), 7.18–7.13 (2H, m), 3.62 (2H, s), 2.10–2.05 (3H, m), 1.93–1.89 (6H, m), 1.78–1.72
(6H, m). 13C NMR (151 MHz, d6 −DMSO): δ = 173.2, 141.1, 134.3, 126.9, 123.8, 118.5, 113.7,
110.8, 107.7, 43.4, 36.4, 35.5, 31.0, 28.5. HRMS (ESI-[+Na]) m/z: Calcd for C20H23NNaO2
332.1626; Found 332.1615.
3. Results
3.1. Integration of OsTIR1WT and OsTIR1F74A Expression Constructs at the arg3-D4 Locus
OsTIR1 is the most commonly used AID system auxin receptor F-box protein. More-
over, in budding yeast, OsTIR1 has been shown to work at high temperatures and expres-
sion of OsTIR1 from the constitutive alcohol dehydrogenase gene (ADH1) promoter does
not affect cell growth [1]. We therefore wished to test OsTIR1 not fused to Skp1 in a new
fission yeast AID system.
We developed a set of plasmids to integrate the OsTIR1WT and OsTIR1F74A expression
constructs at the S. pombe arg3-D4 locus. We sequenced the arg3-D4 locus [24] (Figure S1)
to determine the region deleted and synthesised this sequence and approximately 500bp
flanking the deletion site. These flanking sequences allow integration of the deleted
arg3 gene fragment at the arg3-D4 locus and transformants can be screened for arginine
prototrophy. Synthesis of this fragment allowed for insertion of an MCS (NheI-NdeI-SphI-
XmaI-SacI-PstI-SalI-SpeI) and the removal of restriction enzyme recognition sites from the
arg3 gene sequence which may hinder subsequent cloning events. The synthesised gene
fragment was cloned into pUC19* (where * denotes the removal of the NdeI restriction
enzyme recognition site from the plasmid backbone) to create MCS-Sp.arg3+/pUC19*.
Expression cassettes consisting of an MCS site flanked by approximately 820bp of
the S. pombe adh1 promoter and 160bp of the S. cerevisiae ADH1 terminator sequences
were constructed. Three individual constructs were created each containing different
adh1 promoter strengths. The strongest promoter strength was the wild-type adh1 pro-
moter sequence (Padh1) followed by adh15 promoter (Padh15), a weak derivative of the
adh1 promoter [11] and finally the adh81 promoter (Padh81) a much weaker derivative of
Padh1 [31]. These three expression constructs were cloned into MCS-Sp.arg3+/pUC19*
to create Padh1-MCS-TADH1-Sp.arg3+/pUC19*, Padh15-MCS-TADH1-Sp.arg3+/pUC19* and
Padh81-MCS-TADH1-Sp.arg3+/pUC19*, respectively (MCS = NdeI-XmaI-SacI-PstI-SalI).
For the new AID system, human-codon optimised OsTIR1WT-NLS (NLS: nuclear local-
isation signal) was gene synthesised and cloned into Padh1-MCS-TADH1-Sp.arg3+/pUC19* to
create Padh1-OsTIR1WT-NLS-TADH1-Sp.arg3+/pUC19*. For AID version 2 (AID2), human-
codon optimised OsTIR1F74A-NLS was gene synthesised and cloned into Padh1-MCS-
TADH1-Sp.arg3+/pUC19* to create Padh1-OsTIR1F74A-NLS-TADH1-Sp.arg3+/pUC19*. The
OsTIR1F74A mutation corresponds to the AtTIR1 auxin-binding site mutation F79A identi-
fied by Yamada et al. [18] and used by Nishimura et al. [19] (see also Figure S3). The NLS
directs the system to specifically deplete nuclear proteins. The plasmids Padh1-OsTIR1WT-
NLS-TADH1-arg3+/pUC19* and Padh1-OsTIR1F74A-NLS-TADH1-Sp.arg3+/pUC19* were re-
stricted with NotI restriction enzyme and the linear fragments used to transform AW1655
(bleMX6-arg3-D4). Transformants were screened for arginine prototrophy and successful
integrants confirmed by genomic PCR and sequencing (Figure 1B). This created strains
Padh1-OsTIR1WT (AW1762) and Padh1-OsTIR1F74A (AW1703). Expression of OsTIR1WT and
OsTIR1F74A was confirmed by immunoblot analysis and, as shown previously [17], the
F74A substitution does not significantly affect stability of the TIR1 protein (Figure 1C).
Expression of OsTIR1WT or OsTIR1F74A from the strong constitutive adh1 promoter does
not affect cell growth rate, with doubling times of Padh1-OsTIR1WT and Padh1-OsTIR1F74A
cells comparable to wild-type cells (Figure 1D). As cellular levels of TIR1 have been shown
to be a limiting factor for auxin response [10,32,33], we predict that increasing the TIR1
expression level will increase AID efficiency.
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3.2. Plasmids for C-Terminal AID Tagging
To allow the C-terminal tagging of proteins of interest, we developed a set of plasmids
containing the full-length A. thaliana auxin-responsive AUX/IAA protein IAA17 gene
sequence. The tagging constructs also include a sequence encoding a flexible 10-amino-acid
linker (Gly-Gly-Ser-Gly-Gly-Ser-Gly-Ser-Gly-Ala) that will be inserted between the protein
of interest and the AID-tag. This was included to help minimise loss of either target protein
or AID-tag function. The plasmids also included approximately 530 bp of S. pombe urg1
downstream sequence to act as a transcription terminator and the antibiotic resistance
cassette, kanMX6, which allows selection of G418-resistant cells (Figure 1E).
To detect AID-tagged proteins by immunoblotting using commercial antibodies, a
series of additional short epitope tag sequences were fused to the C-terminus of the AID
tag. These tags included three copies of the influenza virus hemagglutinin (HA) epitope
tag (3HA), five copies of the human c-myc (Myc) epitope (5Myc) and a single copy of the
V5 tag derived from the P and V protein of the simian virus 5 (SV5, a paramyxovirus). The
AID and epitope tags were separated by a short 6-amino-acid flexible linker (Gly-Ala-Gly-
Ala-Gly-Ala) (Figure 1E).
To provide an option to constitutively reduce AID-tagged protein expression levels
from the constructs outlined above, we inserted the 157 bp DSR element derived from
the S. pombe spo5 gene directly downstream of the tag stop codon (Figure 1E). Levels of
yEGFP expressed from the uracil-inducible urg1 locus are reduced approximately 25-fold
by the spo5DSR element compared to the no DSR control [23]. The spo5DSR element
contains 5 copies of the hexanucleotide motif U(U/C)AAAC shown to be highly enriched
in DSR elements [22]. To increase the efficiency of the spo5DSR element and further reduce
AID-tagged protein levels, two sequences similar to the core motif were mutated to match
the hexanucleotide DSR motif (Figure S2). This new DSR element, termed ‘eDSR’, was
introduced into the AID-plasmids, replacing spo5DSR. The full set of plasmids are shown
in Figure 1E.
The AID-tagging constructs were cloned into the Cre-expression plasmid pAW8,
allowing for rapid and efficient C-terminal fusion of the AID-tag using Cre-mediated
cassette exchange [27]. These tagging construct plasmids are also compatible with PCR-
based genomic strategies with the primer sequences required to amplify the series of AID
constructs shown in Figure 1F.
3.3. Testing the New S. pombe AID/OsTIR1(WT) System
As a target of degradation, we used Mcm4, a component of the DNA replication MCM
complex to test the new AID/OsTIR1 system. Mcm4 is an essential protein and mcm4∆
cells are inviable. The i-AID system (Padh15-Skp1-AtTIR1) was used previously to deplete
Mcm4 [10] and allows direct comparison of the efficiency of the two systems. Mcm4 was
successfully C-terminally AID-tagged using a PCR-mediated approach using the plasmids
outlined in Figure 1E. The mcm4-AID strain was then crossed to strains expressing Padh15-
skp1-AtTIR1 or Padh1-OsTIR1WT and the resulting strains were spotted onto a YEA plate or
YEA plates containing the synthetic auxin NAA at 500 µM and the plates were incubated
at 25 ◦C, 30 ◦C or 36 ◦C for 3 days (Figure 1G). Unlike Skp1-AtTIR1 expressing i-AID cells,
expression of OsTIR1 from the strong adh1 constitutive promoter showed no inhibition
in cell growth, as has previously been observed for budding yeast [1]. Although mcm4-
AID skp1-AtTIR1 cell growth was severely inhibited at 25 ◦C by the presence of auxin,
increasing the temperature to 30 ◦C reduced this inhibition and growth rates were more
similar to WT (Figure 1G). However, mcm4-aid OsTIR1 WT cells showed complete loss of
cell viability when grown in the presence of auxin at 25 ◦C and, more importantly, also at
30 ◦C (Figure 1G). The relative thermostability of OsTIR1 compared to AtTIR1 has been
previously reported [1] and explains the improved performance observed for our new AID
system with respect to temperature. Overall, these data clearly demonstrate the significant
improvement in degradation efficiency when using Padh1-OsTIR1 as opposed to systems
involving Padh15-skp1-AtTIR1.
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3.4. Further Characterisation of the S. pombe AID/OsTIR1WT System
To determine the rate and percentage reduction in AID-tagged protein levels following
addition of auxin, we created the strains mcm4-AID-5myc and mcm4-AID-V5 using the
plasmids outlined in Figure 1E (we were unable to create mcm4-AID-3HA). As we found the
signal-to-noise ratio of the anti-V5 antibody was significantly higher than that for anti-Myc,
mcm4-AID-V5 cells were used to study protein levels. Complete inviability in the presence
of NAA of mcm4-AID-V5 OsTIR1WT cells demonstrate that the V5 epitope tag does not
compromise AID degron function (Figure 2A).
mcm4-AID-V5 OsTIR1WT cells were grown to mid-log phase, synthetic auxin NAA was
added to a final concentration of 500 µM and total protein extracted at various timepoints.
Total protein was also extracted from mcm4+ (untagged Mcm4) and mcm4-AID-V5 cells
with no OsTIR1. Following immunoblotting using anti-V5 antibodies and, as a loading
control, anti-tubulin, the degradation kinetics were determined (Figure 2B). Quantification
of AID-tagged protein levels reveal a 14% reduction in Mcm4-AID-V5 protein levels in cells
exogenously expressing OsTIR1 in the absence of NAA. The chronic auxin-independent
depletion of AID-tagged proteins by TIR1 has been extensively reported [34–36]. After
addition of NAA a rapid depletion of cellular levels of Mcm4-AID-V5 was observed with a
90% reduction after 15 min. However, detectable levels of Mcm4-AID-V5 were observed
3 h after addition of NAA with approximately 5% of protein remaining (Figure 2C).
Using Mcm4 to assess the efficiency of the OsTIR1 auxin-inducible degron system
is limited because Mcm4 is an essential protein and a reduction in protein level by ap-
proximately 95% leads to complete cell inviability (Figure 2A,C). Therefore, we chose to
also study the DNA repair protein Rad52 because, unlike Mcm4, Rad52 is a non-essential
protein and rad52∆ cells are viable. Depletion of Rad52 can be monitored phenotypically as
rad52∆ cells display a slow-growth phenotype and are hyper sensitive to DNA damaging
agents such as hydroxyurea (HU) [37].
We successfully AID-tagged Rad52 via a PCR-based approach using the plasmids
outlined in Figure 1E as PCR templates. Spot test analysis shows that rad52-AID and rad52-
AID-V5 cells grow at WT rates and show WT levels of resistance to the genotoxic agent HU,
meaning that the AID and AID-V5 tags do not adversely affect Rad52 function (Figure 2D).
This is in contrast to rad52∆ cells that are both slow growing and are hypersensitive to HU
treatment with significant levels of cell death observed at low HU concentrations (2 mM).
In the presence of NAA, however, rad52-AID OsTIR1WT and rad52-AID-V5 OsTIR1WT
cells exhibit increased sensitivity to HU when compared to untagged Rad52 control cells,
but only at higher HU concentrations (4 mM). This indicates that significant levels of
Rad52-AID protein remain when NAA is present (Figure 2D).
We used rad52-AID-V5 cells to monitor protein levels. rad52-AID-V5 OsTIR1WT cells
were grown to mid-log phase, NAA was added to a final concentration of 500 µM and total
protein extracted at various timepoints. As with mcm4-AID-V5 OsTIR1WT cells, chronic
auxin-independent depletion of Rad52-AID-V5 by OsTIR1 was observed with protein
levels reduced by approximately 14% compared to rad52-AID-V5 cells (Figure 2F). As
with Mcm4, the addition of NAA induced a rapid depletion of Rad52-AID-V5, with levels
reduced by 78% within 15 min but Rad52-AID-V5 protein levels were detectable even after
overnight treatment (18 h). Residual levels of Rad52-AID-V5 in cells expressing OsTIR1 in
the presence of NAA are comparable to those seen for Mcm4—approximately 4% relative
to no TIR1 (Figure 2F).
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Figure 2. Regulation of Mcm4 and Rad52 activity using AID/OsTIR1WT. (A) Isogenic strains with indicated genotypes
(mcm4+ (AW279), mcm4-AID (AW1893), mcm4-AID-V5 (AW1899), OsTIR1WT (AW1762), mcm4-AID OsTIR1WT (AW1923),
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mcm4-AID-V5 OsTIR1WT (AW1935)) were spotted onto YEA plates and plates containing 500 µM NAA. Plates were grown
at 30 ◦C for 3 days. The experiment was repeated and similar results were obtained. (B) Representative immunoblot on total
protein extract from mcm4+ (AW279), mcm4-AID-V5 (AW1899) and mcm4-AID-V5 OsTIR1WT (AW1935) cells treated with
500 µM NAA and sampled at indicated time points and detected using anti-V5 antibody. Anti-tubulin was used as a loading
control. (C) Graph of quantified anti-V5 signal normalised against anti-tubulin signal for (B) (data represented as the mean
values +/− SD of three independent experiments). (D) Isogenic strains with indicated genotypes (rad52+ (AW279), rad52-
AID (AW1901), rad52-AID-V5 (AW1907), OsTIR1WT (AW1762), rad52-AID OsTIR1WT (AW1990), rad52-AID-V5 OsTIR1WT
(AW1996), rad52∆ (AW1581)) were spotted onto YEA plates and plates containing 500 µM NAA and/or genotoxic agent
hydroxyurea (HU) at indicated concentrations. Plates were grown at 30 ◦C for 3 days. The experiment was repeated and
similar results were obtained. (E) Representative immunoblot on total protein extract from rad52+ (AW279), rad52-AID-V5
(AW1907) and rad52-AID-V5 OsTIR1WT (AW1996) cells treated with 500 µM NAA and sampled at the indicated time points
and detected using anti-V5 antibody. Anti-tubulin was used as a loading control. (F) Graph of quantified anti-V5 signal
normalised against anti-tubulin signal (data represented as the mean values +/− SD of three independent experiments).
Overall, these data demonstrate the effectiveness of the AID/OsTIR1WT system. AID-
tagged proteins are rapidly degraded in the presence of NAA with overall levels reduced
approximately 20-fold. However, detectable levels of AID-tagged protein remain. For
an essential protein such as Mcm4, this residuary level is low enough to render the cell
inviable and thus a conditional null-mutant phenotype was obtained. However, for a
non-essential gene, such as Rad52, this residual level did not manifest a conditional null
phenotype: NAA-treated cells only showed sensitivity to HU at concentrations that were
higher than those required to kill rad52-deleted cells. Moreover, the effectiveness of the
AID/OsTIR1WT system is potentially compromised by the NAA-independent association
of AID-tagged proteins with OsTIR1, resulting in levels being reduced by approximately
14% relative to no TIR1 controls.
3.5. Using the AID2/OsTIR1F74A System in S. pombe
Recent AID systems have made use of synthetic auxin–TIR1 pairs that function or-
thogonally to the natural auxin signalling pathway. The systems involve an auxin-binding
site mutant and a 5-substituted synthetic auxin and overcome problems associated with
the original AID system, namely, the requirement for a high dose of auxin and the auxin-
independent degradation of AID-tagged target proteins. The new AID systems (termed
AID version 2 or ‘AID2′) have been characterised for use in chicken DT40 cells, budding
yeast, mammalian cells and mice and have been shown to require a markedly lower ligand
concentration for the association of TIR1 with the AID-tag and no detectable basal degra-
dation of AID-tagged proteins was observed [6,19]. The rate of degradation has been also
shown to be even quicker in AID2 compared to AID [6].
To test an AID2 in fission yeast, we construct a system analogous to that described by
Yamada et al. [18]. We synthesised the 5-substituted auxin 5′adamantyl-IAA (Figure 3A) and
created a strain that endogenously expresses the high-affinity-binding partner OsTIR1F74A,
corresponding to AtTIR1F79A, using the arg3-D4 integration expression vector system we
have developed (Figure 1B). Growth analysis showed that overexpression of OsTIR1F74A
using the strong constitutive adh1 promoter does not affect cell growth (Figure 1D). We
crossed the OsTIR1F74A strain to the mcm4-AID and mcm4-AID-V5 strains and, using
spot test analysis, tested a range of concentrations of the AID2 inducer 5′adamantyl-IAA
(100 nM, 10 nM and 1 nM). We found that a 5′adamantyl-IAA concentration of 1 nM
was sufficient to generate a lethal phenotype and that 10 nM was, upon microscopic
examination, able to completely inhibit cell growth (Figure S5A and Figure 3B). The 10 nM
represents a 5,000-fold reduction in ligand concentration compared to OsTIR1WT/NAA.
Interestingly, the AID2/OsTIR1F74A system also functions better at the higher growth
temperature of 36 ◦C (Figure 3B; compare with Figure 1G). This clearly demonstrates that
the AID2 OsTIR1F74A/5′adamantyl-IAA system is fully functional in fission yeast and,
with respect to Mcm4, requires a significantly lower ligand concentration compared to
AID/OsTIR1WT/NAA.
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Figure 3. Regulation of Mcm4 and Rad52 activity using AID2/OsTIR1F74A. (A) Schematic illustration showing synthesis of 2-
[5-(adamantan-1-yl)-1H-indol-3-yl]acetic acid (5′adamantyl-IAA). (1) 1-Bromoadamantane, ZnCl2, 1,1,2,2-tetrachloroethane,
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80 ◦C, 72 h, 51%; (2) NIS, TsOH.H2O, MeCN, rt, 24 h, 98%; (3) trimethylsilyacetylene, Pd(PPh3)2Cl2, CuI, THF:NEt3 (1:1),
80%; (4) TBAF, THF, 80 ◦C, 16 h, 76%; (5) oxalyl chloride, Et2O, rt, 16 h; (6) NaH2PO2.H2O, Pd/C, H2O/1,4-dioxane (1:5),
100 ◦C, 72 h, 36% over two steps. (B) Isogenic strains with the indicated genotypes (mcm4+ (AW279), mcm4-AID (AW1893),
mcm4-AID-V5 (AW1899), OsTIR1F74A (AW1703), mcm4-AID OsTIR1F74A (AW1925), mcm4-AID-V5 OsTIR1F74A (AW1937))
were spotted onto YEA plates and plates containing 10 nM 5′adamantyl-IAA (5′a-IAA). Plates were grown at indicated
temperatures for 3 days. The experiment was repeated and similar results were obtained. (C) Representative immunoblot on
total protein extract from mcm4+ (AW279), mcm4-AID-V5 (AW1899) and mcm4-AID-V5 OsTIR1F74A (AW1937) cells treated
with 10 nM 5′adamantyl-IAA (5′a-IAA) and sampled at the indicated time points and detected using anti-V5 antibody.
Anti-tubulin was used as a loading control. (D) Graph of quantified anti-V5 signal normalised against anti-tubulin signal
for (C) (data represented as the mean values +/− SD of three independent experiments). (E) Isogenic strains with the
indicated genotypes (rad52+ (AW279), rad52-AID (AW1901), rad52-AID-V5 (AW1907) OsTIR1F74A (AW1703), rad52-AID
OsTIR1F74A (AW1962), rad52-AID-V5 OsTIR1F74A (AW1968), rad52∆ (AW1581)) were spotted onto YEA plates and plates
containing 100 nM 5′adamantyl-IAA (5′a-IAA) and/or genotoxic agent hydroxyurea (HU) at the indicated concentrations.
Plates were grown at 30 ◦C for 3 days. The experiment was repeated and similar results were obtained. (F) Representative
immunoblot on total protein extract from rad52+ (AW279), rad52-AID-V5 (AW1907) and rad52-AID-V5 OsTIR1F74A (AW1968)
cells treated with 100 nM 5′adamantyl-IAA (5′a-IAA) and sampled at indicated time points and detected using anti-V5
antibody. Anti-tubulin was used as a loading control. (G) Graph of quantified anti-V5 signal normalised against anti-tubulin
signal for (F) (data represented as the mean values +/− SD of three independent experiments).
Immunoblot analysis shows no auxin-independent depletion of Mcm4-AID-V5 in
cells expressing OsTIR1F74A (Figure 3C,D) in contrast to mcm4-AID-V5 OsTIR1WT cells
(Figure 2B,C). Furthermore, Figure 3C,D show that the kinetics of depletion are faster
in mcm4-AID-V5 OsTIR1F74A cells after the addition of 5′adamantyl-IAA (94% reduction
after 15 min) when compared to mcm4-AID-V5 OsTIR1WT cells treated with NAA (see
Figure 2B,C) (90% reduction after 15 min). These faster kinetics may be due to the higher
affinity of the 5′adamantyl-IAA-induced OsTIR1F74A interaction when compared to the
NAA-induced OsTIR1WT interaction [18]. Surprisingly, steady-state proteins levels after
addition of 5′adamantyl-IAA to mcm4-AID-V5 OsTIR1F74A cells are similar to those seen for
mcm4-AID-V5 OsTIR1WT cells after NAA addition (approximately 4% of no TIR1 levels).
To test AID2 using Rad52, rad52-AID OsTIR1F74A and rad52-AID-V5 OsTIR1F74A cells
were created. We tested a range of 5′adamantyl-IAA concentrations (1,000 nM, 100 nM
and 10 nM) using spot test analysis of rad52-AID OsTIR1F74A cells (Figure S5B) and deter-
mined that a concentration of 100 nM 5′adamantyl-IAA was required to maximally induce
the rad52 phenotype—a 500-fold lower concentration as compared to NAA. The Rad52-
AID/OsTIR1F74A system is also clearly more efficient than the Rad52-AID/OsTIR1WT
system. Growth rates of rad52-AID OsTIR1F74A cells were reduced in the presence of
5′adamantyl-IAA compared to rad52-AID cells (Figure 3E), whereas rad52-AID OsTIR1WT
cells treated with NAA do not show reduced growth rate (Figure 2D). Furthermore, rad52-
AID OsTIR1F74A cells treated with 5′adamantyl-IAA show a marked reduction in cell
viability when grown in the presence of HU (Figure 3E) when compared to rad52-AID
OsTIR1WT cells treated with NAA (Figure 2D). However, despite improved efficiency of
Rad52 degradation by AID2, rad52-AID/OsTIR1F74A cells treated with 5′adamantyl-IAA
are not as slow growing nor as sensitive to HU as rad52∆ cells, implying residuary Rad52
activity remains in these cells.
As seen for Mcm4-AID-V5, immunoblot analysis shows no auxin-independent deple-
tion of Rad52-AID-V5 in cells expressing OsTIR1F74A (Figure 3F,G). Furthermore, Figure 3G
shows that the kinetics of depletion are faster in rad52-AID-V5 OsTIR1F74A cells after the
addition of 5′adamantyl-IAA (94% reduction after 15 min) when compared to rad52-AID-
V5 OsTIR1WT cells treated with NAA (Figure 2B,C) (77% reduction after 15 min). The
steady-state protein levels after addition of 5′adamantyl-IAA to rad52-AID-V5 OsTIR1F74A
cells are significantly lower than those seen for rad52-AID-V5 OsTIR1WT cells treated with
NAA (1.6% and 3.6%, respectively), which explains the slower growth rates and increased
HU sensitivity described above.
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As recently shown by others [6], the AID2 (OsTIR1F74A/5′adamantyl-IAA) system
is clearly an improvement on the AID (OsTIR1WT/NAA) system with faster degradation
kinetics, much lower ligand concentrations and no auxin-independent depletion of AID-
tagged proteins. However, despite this increase in functionality, observable levels of
AID-tagged proteins remain.
3.6. Use of DSR Elements Allows Generation of Stricter S. pombe Mutants
Despite significantly improving the fission yeast auxin-dependent degron system,
the reduction in protein levels was insufficient to obtain a conditional rad52-null mutant
phenotype. To achieve such a phenotype, other levels of regulation are therefore required.
The regulation of transcription is an effective and well-defined option but requires ad-
ditional genome editing with the insertion of a regulatable promoter sequence and the
manipulation of the growth media in order to downregulate transcription. Determinant of
Selective Removal (DSR) elements have previously been shown to effectively modulate
protein levels [23]. As DSR elements are usually located at the 3′ end of the transcript they
can easily be incorporated into the AID-plasmid sequence (Figure 1E) and therefore require
no extra steps. The use of DSRs does, however, have the disadvantage that protein levels
are constitutively lowered.
Using the DSR containing AID-plasmids outlined in Figure 1E, we C-terminally
tagged the rad52 locus with AID-spo5DSR, AID-eDSR, AID-V5-spo5DSR and AID-V5-
eDSR. To determine the relative effectiveness of the spo5DSR and eDSR on Rad52-AID-
V5 levels, Western blot analysis was performed. Immunoblot of total protein extracted
from logarithmically growing rad52-AID (NO DSR), rad52-AID-spo5DSR and rad52-AID-
eDSR cells shows the effect of DSR elements on constitutively reducing protein levels
(Figure 4A). The previously untested eDSR element—a mutant form of spo5DSR engineered
to contain two additional copies of the DSRcore element—is more effective at reducing
levels than spo5DSR. Quantification of Rad52-AID-V5 proteins levels revealed that the
spo5DSR element reduces the level on average by 84% and the eDSR element by 98%
(Figure 4B). As above, addition of 5′adamantyl-IAA to rad52-AID-spo5DSR and rad52-
AID-eDSR cells exogenously expressing OsTIR1F74A caused rapid depletion of Rad52-AID-
tagged proteins (Figure 4C,D, respectively). Interestingly, in rad52-AID-V5-spo5DSR cells
treated with 5′adamantyl-IAA, steady-state protein levels were still detectable despite a
reduction in initial protein levels by 84% (Figure 4B,C). This suggests that as the AID-
tagged protein level is reduced, the efficiency of degradation is also reduced. However, in
rad52-AID-V5-eDSR cells treated with 5′adamantyl-IAA, where initial levels are reduced
by 98%, steady-state protein levels were un-detectable (Figure 4D).
The effects of the reduction in Rad52-AID protein levels due to the DSR elements
are revealed by spot test analysis (Figure 4E). Predictably, as levels of Rad52 decrease in
rad52-AID (NO DSR), rad52-AID-spo5DSR and rad52-AID-eDSR cells, sensitivity to 4 mM
HU increases. Interestingly, HU sensitivity was slightly increased when a V5 tag for
each of these strains was also present, implying that the V5 tag reduces Rad52 activity
(Figure 4E). In the presence of 100 nM 5′adamantyl-IAA, rad52-AID-spo5DSR OsTIR1F74A
cells exhibit a slow growth phenotype that is significantly more pronounced as seen for
rad52-AID/OsTIR1F74A cells, but not as slow growing as rad52∆ cells (Figure 4E). This
pattern is repeated for plates supplemented with HU. rad52-AID-spo5DSR OsTIR1F74A cells
exhibit sensitivity to HU that is significantly more severe than that seen for rad52-AID
OsTIR1F74A cells but not as sensitive as rad52∆ cells. Unexpectedly, when grown in the
presence of 5′adamantyl-IAA, rad52-AID-eDSR OsTIR1F74A cells are as slow growing and
as sensitive to HU as rad52-AID-spo5DSR OsTIR1F74A cells. This was surprising as the
level of Rad52-AID-V5 protein is clearly lower when associated with eDSR than that of
Rad52-AID-V5 associated with spo5DSR (Figure 4C,D, respectively). This may reflect the
sensitivity limit of the spot test assay.
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spo5DSR OsTIR1F74A (AW1976) cells treated with 100 nM 5′adamantyl-IAA (5′a-IAA) and sampled at indicated time points 
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Figure 4. DSR elements improve AID2/OsTIR1F74A. (A) Representative immunoblot on total protein extract from rad52+
(AW279), rad52-AID-V5 (NO DSR) (AW1907), rad52-AID-V5-spo5DSR (spo5DSR) (AW1921) and rad52-AID-V5-eDSR (eDSR)
(AW2017) cells detected using anti-V5 antibody. Anti-tubulin was used as a loading control. (B) Histogram of quantified anti-
V5 signal normalised against anti-tubu in signal for (A) (data represented s the mean values +/− SD of three independent
experiments). (C) Representative immunoblot on total protein extract from control and rad52-AID-V5-spo5DSR OsTIR1F74A
(AW1976) cells treated with 100 nM 5′adamantyl-IAA (5′a-IAA) and sampled at indicated time points and detected using
anti-V5 antibody. Anti-tubulin was used as a loading control. (D) Representative immunoblot on total protein extract from
control and rad52-AID-V5-eDSR OsTIR1F74A (AW2026) cells treated with 100 nM 5′adamantyl-IAA (5′a-IAA) and sampled
at the indicated time points and detected using anti-V5 antibody. Anti-tubulin was used as a loading control. (E) Isogenic
strains with indicated genotypes (rad52+ (AW279), rad52-AID-spo5DSR (AW1915), rad52-AID-V5-spo5DSR (AW1921), rad52-
AID-eDSR (AW2011), rad52-AID-V5-eDSR (AW2017), OsTIR1F74A (AW1703), rad52-AID-spo5DSR) OsTIR1F74A (AW1970),
rad52-AID-V5-spo5DSR OsTIR1F74A (AW1976), rad52-AID-eDSR OsTIR1F74A (AW2024), rad52-AID-V5-eDSR OsTIR1F74A
(AW2026), rad52∆ (AW1581)) were spotted onto YEA plates and plates containing 100 nM 5′adamantyl-IAA (5′a-IAA) and/or
genotoxic agent hydroxyurea (HU) at the indicated concentrations. Plates were grown at 30 ◦C for 3 days. Experiment was
repeated and similar results obtained.
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The use of DSR elements clearly reduces AID-target protein levels leading to a more
penetrative phenotype. Frustratingly, despite the higher efficiency of the eDSR element
compared to spo5DSR, rad52-AID-eDSR OsTIR1F74A and rad52-AID-spo5DSR OsTIR1F74A
are as equally sensitive to HU when 5′adamantyl-IAA is present (Figure 4E) and neither
are as sensitive as rad52∆ cells. However, the residual level of Rad52 is very low.
4. Discussion
Here, we describe the construction of a powerful protein-depletion system in S. pombe
based upon the auxin-inducible degron (AID) system. We created two sets of plasmid
vectors for this study. The first is a series of stable integration expression vectors that target
the S. pombe arg3-D4 locus (Figure S1). The vectors include the arg3 gene sequence that is
deleted at the arg3-D4 locus, a range of S. pombe adh1 gene promoter sequences of varying
strengths and, to clone the gene to be expressed, an MCS. The plasmid vectors are designed
to integrate a single stable copy at the arg3-D4 locus restoring arginine prototrophy.
The second set of plasmids are to fuse the AID tag to the C-terminus of the target
protein (Figure 1E). The AID constructs include a flexible ten amino acid linker, the full-
length A. thaliana IAA17 AID tag (a 229-amino-acid peptide) and, for the detection of AID-
tagged proteins by immunoblot, a series of common epitope tags for which commercial
antibodies are available. Also included is the option of one of two ‘Determinants of
Selective Removal’ (DSR) elements: one derived from the S. pombe spo5 gene and an
improved, mutated version of the spo5DSR termed eDSR. DSR elements usually prevent
the accumulation of meiosis-specific mRNAs during the mitotic cell cycle in fission yeast
by targeting them for destruction by nuclear exosomes. Here, they result in the constitutive
reduction in AID-tagged protein levels. The AID constructs can be inserted into the
genome using Cre recombinase-mediated cassette exchange [27] or by using a standard
PCR-mediated tagging procedure commonly used for fission yeast.
Using the integration vectors, we successfully inserted at the arg3-D4 locus sequences
to express the auxin receptor TIR1 protein from O. sativa (OsTIR1WT) and an auxin-binding
site mutant of OsTIR1, OsTIR1F74A. Importantly, both forms of OsTIR1 were not fused
to Skp1. Overexpression of either OsTIR1WT or OsTIR1F74A from the strong constitutive
adh1 promoter had no observable effect on cell growth. OsTIR1F74A binds the auxin analog
5′adamantyl-IAA with a higher affinity than OsTIR1 and natural auxin [18]. This synthetic
pairing forms the basis of AID version 2 (AID2) the equivalent of which has recently been
shown to perform better than AID in chicken DT40 cells, budding yeast, mammalian cells
and mice [6,19].
Both AID and AID2 produced a conditional Mcm4 null phenotype at 30 ◦C. However,
as predicted, AID2 required much lower ligand concentration (5,000-fold less), showed
slightly faster degradation kinetics and no auxin-independent proteolysis of Mcm4 or
Rad52 as compared with AID. The effective concentration of 5-adamaltyl-IAA was higher
for Rad52 (100 nM) than for Mcm4 (10 nM). This was surprising considering quantitative
analysis of the fission yeast proteomes has shown that in vegetatively growing cells there
are approximately 3-fold more Mcm4 protein molecules than Rad52 protein molecules [38]
and Nishimura et al. [19] have demonstrated that depletion of AID-tagged CENP-H by
5′-adamantyl-IAA is dose dependent. The AID system may therefore be intrinsically better
suited to regulating essential proteins: below a critical threshold level, the cell becomes
inviable and a null phenotype achieved. Despite the higher ligand concentration, a lower
steady-state protein level and the use of highly effective DSR elements, residual Rad52
activity remains after depletion (Figure 4C) (due possibly to TIR1 being limiting). Tandem
arrays of functional truncated forms of the AID tag have been used to dramatically increase
the efficiency of previous AID systems (termed ‘3XminiAID’; [39,40]). Use of a 3Xmini-
AID-style tag may be sufficient to achieve a conditional-null Rad52 phenotype and we are
currently testing this. However, anecdotal evidence from our lab suggests that fusion of
the 3Xmini-AID tag to the target protein either partially or completely removes protein
function more often than with full-length AID.
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Despite no conditional null phenotype for Rad52 being achieved using either AID
system, AID2 performed better than AID. The use of DSR elements successfully improved
the severity of the conditional mutant phenotype, but a very low level of Rad52 activity
remains. Despite the eDSR reducing initial protein levels by 94% and spo5DSR by 74% and
immunoblots showing less Rad52-AID in rad52-AID-eDSR cells treated with 5′adamantyl-
IAA than rad52-AID-spo5DSR cells treated with 5′adamantyl-IAA, rad52-AID-eDSR and
rad52-AID-spo5DSR cells surprisingly exhibited the same level of HU sensitivity.
A detailed protocol for the synthesis of 5′adamantyl-IAA is provided in the materi-
als and methods section. In addition, 5′adamantyl-IAA is now commercially available
(https://www.tcichemicals.com/GB/en/p/A3390 (accessed on 6 June 2021)). We found
5′adamantyl-IAA to be more chemically stable than NAA. We incubated an aliquot of
5′adamantyl-IAA at room temperature for 7 days and, when tested, we observed no
loss in activity (Figure S4). In our hands, NAA was found to be chemically labile with
freeze/thawing of frozen stocks reducing activity. Only freshly prepared NAA stocks
were used.
Overall, we have significantly improved the utility of the auxin-inducible degron
system in S. pombe and this should enhance the study of gene function in vivo by more
effectively reducing the levels of gene product. As auxin response has been shown to be
intrinsically linked to cellular TIR1 concentration [10,32,33], the increase in TIR1 expression
level is the probable reason for the concomitant increase in AID efficiency. The relative
thermostability of OsTIR1 compared to AtTIR1 [1] also means that our new system works
also more efficiently at the higher temperatures of 30 and 36 ◦C.
The OsTIR system was further enhanced by introducing the synthetic pairing of
the binding-site mutant OsTIR1F74A with the auxin analogue 5′adamantyl-IAA (AID2).
Because neither the AID or AID2 systems abolish AID-tagged protein levels completely,
we also introduced the ability to regulate the initial protein levels by introducing a DSR
sequence that restricts the mRNA level and thus reduces the starting protein level. This
may be particularly helpful when it is desirable to reduce gene function as much as possible
to approach a null phenotype. While both the AID and AID2 systems are highly effective
for regulating essential proteins to achieve a null-like phenotype, as seen for Mcm4, we
note that residual activity remains when assessing a non-essential gene for function, even
when combining AID2 with DSR elements.
Supplementary Materials: The following are available online at https://www.mdpi.com/article/10
.3390/genes12060882/s1, Figure S1: Overview of the arg3-D4 integration expression vector system.
(a) Sequence of the arg3-D4 locus [24]. Underlined capital letters: pBR322 plasmid sequence; sequence
highlighted in yellow: arg3-D4 homology used in construction of arg3+ expression vectors (see b).
(b) Schematic illustration showing arg3-D4 integration expression vectors. HOM: the two homology
sequences used to insert the linear expression construct at the arg3-D4 locus (see a); MCS: multiple
clone site; number in parenthesis after plasmid name: Addgene ID. (c) Schematic illustration showing
integration of Padh1-OsTIR1WT-NLS-TADH1 and Padh1-OsTIR1F74A-NLS-TADH1 expression constructs
at arg3-D4 locus using arg3-D4 integration expression vector system; cmb1: gene neighbouring arg3.
Figure S2: The spo5DSR and eDSR elements. (a) The 157bp DSR element from the S. pombe spo5 gene
downstream region as identified by Harigaya et al. [20]. Sequences identical to core hexanucleotide
U(U/C)AAAC motifs are highlighted. Boxed sequences are those identified as similar to the core
motif. (b) The 158 bp eDSR sequence derived from the spo5DSR element. Underlined sequences are
additional core TTAAAC motifs (mutated bases shown in lower case). Figure S3: Alignment of Oryza
sativa transport inhibitor response protein 1 (OsTIR1) and Arabidopsis thaliana transport inhibitor
response protein 1 (AtTIR1) proteins. AtTIR1 (GeneID 825473) and OsTIR1 (GeneID 4335696) were
aligned using the ClustalW software. Black and grey boxes indicate identical and similar amino
acids, respectively. Position F79 of AtTIR1 and the corresponding F74 of OsTIR1 are arrowed.
Figure S4: 5’adamantyl-IAA is chemically stable. Isogenic strains with indicated genotypes (rad52+
(AW279), rad52-HA-AID, OsTIR1F74A (AW1680), rad52-HA-AID OsTIR1F74A (AW1681), rad52-HA-AID-
spo5DSR OsTIR1F74A (AW1682), rad52-HA-AID-spo5DSR OsTIR1F74A (AW1683), rad52∆ (AW1581))
were spotted onto YEA plates and plates containing 100 nM 5’adamantyl-IAA (5’a-IAA) and/or
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genotoxic agent hydroxyurea (HU) at the indicated concentrations. 5’adamantyl-IAA added to plates
from frozen stock (−20 ◦C stock) or from an aliquot incubated at room temperature for 7 days (7d RT).
Plates were grown at 30 ◦C for 3 days, Figure S5: Titration of 5’adamantyl-IAA to determine effective
ligand concentration. (a) Mcm4-AID. Isogenic strains with indicated genotypes (mcm4+ (AW279),
mcm4-AID (AW1893), OsTIR1F74A (AW1703), mcm4-AID OsTIR1F74A (AW1925)) were spotted onto
YEA plates and plates containing 100 nM 5’adamantyl-IAA (5’a-IAA), 10 nM 5’adamantyl-IAA
(5’a-IAA) and 1 nM 5’adamantyl-IAA (5’a-IAA). Plates were grown at 30 ◦C for 3 days. (b) Rad52-
AID. Isogenic strains with indicated genotypes (rad52+ (AW279), rad52-AID (AW1901), OsTIR1F74A
(AW1703), rad52-AID OsTIR1F74A (AW1962), rad52∆ (AW1581)) were spotted onto YEA plates and
plates containing 1000 nM 5’adamantyl-IAA (5’a-IAA), 100 nM 5’adamantyl-IAA (5’a-IAA) and 10
nM 5’adamantyl-IAA (5’a-IAA). Plates were grown at 30 ◦C for 3 days. Note: each panel in (b) is a
composite of two images (both taken of the same plate) excising irrelevant strains between rad52-AID
and rad52-delete.
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